Ime izdelka: Dehydronandrolone Acetate
Sopomenke: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
MP: 95-98°C
Temp. shranjevanja: Controlled Substance, -20°C Freezer
Videz: beli prah
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, dolgotrajno pridobivanje mišic. To je posledica relativno dolge razpolovne dobe zdravila. Uporabniki poročajo o blagih stranskih učinkih, pri čemer je največji stranski učinek zadrževanje vode.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, dolgotrajno pridobivanje mišic. To je posledica relativno dolge razpolovne dobe zdravila. Uporabniki poročajo o blagih stranskih učinkih, pri čemer je največji stranski učinek zadrževanje vode.
Dehydronandrolon acetate is an effective compound that produces quality, dolgotrajno pridobivanje mišic,pri čemer je največji stranski učinek zadrževanje vode.
| Elementi analize |
Specifikacija |
Rezultati |
| Opis |
White to light yellow crystalline powder |
Bel kristalinični prah |
| Tališče |
≥100℃ |
107℃ |
| Specifična optična rotacija |
-20°～-26° |
-22.5° |
| Izguba pri sušenju |
≤0,5 % |
0.15% |
| Identifikacija |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Kvalificiran |
| Maximum single impurity |
≤1,0 % |
0.3% |
| Skupne nečistoče |
≤5,0 % |
0.8% |
| Test |
≥95,0 % |
99.45% |
| Zaključek |
Kvalificiran |
